Why did Daiichi Sankyo shares drop today?

Management kept full‑year guidance unchanged and the October–December quarter missed market expectations. That combination disappointed investors looking for stronger near‑term momentum. Media coverage also highlighted uncertainty around the next strategy update, which cooled buying interest even as long‑term oncology assets remain a key part of the growth story.

Is Daiichi Sankyo stock attractive at current levels?

The stock trades below its 50‑day and 200‑day averages and near multi‑year support. Trailing P/E is 18.97 with a dividend yield near 2.43%. It could appeal to long‑term holders if strategy clarity improves. Short‑term traders should respect volatility and use defined stops while watching for a base above ¥3,000.

What key levels should I watch on the chart?

Immediate support sits around ¥2,684. A push through the ¥3,000 round number, then toward the 50‑day average near ¥3,421, would signal improving momentum. The 200‑day near ¥3,540 is a larger test. Failing to hold recent lows could invite further downside until stronger buyers emerge.

When is the next earnings report?

The company is scheduled to report on April 23, 2026. Investors should look for any changes to full‑year guidance, updates on the medium‑term plan, and detail on margins, launch curves, and regional sales. Clear milestones and timelines would likely be as important as the headline profit numbers.

Global Market Insights

4568.T Stock Today: January 31 Outlook Kept; Shares Hit Multi-Year Low

ByHuzaifa Zahoor January 31, 2026January 31, 2026

Daiichi Sankyo stock fell to a multi‑year low after the company kept its full‑year outlook unchanged and reported an earnings miss for the October–December quarter. Tokyo‑listed 4568.T dropped on heavy volume as traders questioned the timing and clarity of the next strategy update. We break down the latest price action, valuation markers, and key dates for Japan investors. We also outline what could shift sentiment in the weeks ahead.